• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).《2016年日本脓毒症及脓毒性休克管理临床实践指南》(J-SSCG 2016)
J Intensive Care. 2018 Feb 2;6:7. doi: 10.1186/s40560-017-0270-8. eCollection 2018.
2
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).《2016年日本脓毒症及脓毒性休克管理临床实践指南》(J-SSCG 2016)
Acute Med Surg. 2018 Feb 5;5(1):3-89. doi: 10.1002/ams2.322. eCollection 2018 Jan.
3
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).《2020年日本脓毒症及脓毒性休克管理临床实践指南》(J-SSCG 2020)
Acute Med Surg. 2021 Aug 26;8(1):e659. doi: 10.1002/ams2.659. eCollection 2021 Jan-Dec.
4
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).《2020年日本脓毒症和脓毒性休克管理临床实践指南》(J-SSCG 2020)
J Intensive Care. 2021 Aug 25;9(1):53. doi: 10.1186/s40560-021-00555-7.
5
The Japanese guidelines for the management of sepsis.日本脓毒症管理指南。
J Intensive Care. 2014 Oct 28;2(1):55. doi: 10.1186/s40560-014-0055-2. eCollection 2014.
6
Japanese Clinical Practice Guidelines for Rehabilitation in Critically Ill Patients 2023 (J-ReCIP 2023).《2023年日本危重症患者康复临床实践指南》(J-ReCIP 2023)
J Intensive Care. 2023 Nov 7;11(1):47. doi: 10.1186/s40560-023-00697-w.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
New avenues of sepsis research: obtaining perspective by analyzing and comparing SSCG 2021 and J-SSCG 2020.脓毒症研究的新途径:通过分析和比较2021年脓毒症存活指南(SSCG)和2020年日本脓毒症存活指南(J-SSCG)获取见解
J Intensive Care. 2022 Mar 7;10(1):11. doi: 10.1186/s40560-022-00606-7.
9
Japanese rapid/living recommendations on drug management for COVID-19: updated guidelines (September 2021).日本关于新型冠状病毒肺炎药物管理的快速/现行建议:更新指南(2021年9月)
Acute Med Surg. 2021 Nov 16;8(1):e706. doi: 10.1002/ams2.706. eCollection 2021 Jan-Dec.
10
[Comparison between the 2020 international guidelines for the management of sepsis and septic shock and the Japanese guidelines for the management of sepsis].《2020年脓毒症和脓毒性休克国际管理指南与日本脓毒症管理指南的比较》
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 May;35(5):453-457. doi: 10.3760/cma.j.cn121430-20221227-01119.

引用本文的文献

1
Impact of the Japanese clinical practice guidelines for management of sepsis and septic shock (J-SSCG) 2020 on real-world adherence and interhospital variation: a nationwide inpatient database study.《2020年日本脓毒症和脓毒性休克管理临床实践指南(J-SSCG)对实际依从性和医院间差异的影响:一项全国住院患者数据库研究》
Crit Care. 2025 Jun 3;29(1):225. doi: 10.1186/s13054-025-05482-9.
2
Early management of adult sepsis and septic shock: Korean clinical practice guidelines.成人脓毒症和脓毒性休克的早期管理:韩国临床实践指南
Acute Crit Care. 2024 Nov;39(4):445-472. doi: 10.4266/acc.2024.00920. Epub 2024 Nov 18.
3
Steroid Therapy for Patients with Septic Shock: A Multicenter Observational Study Conducted in Japan.日本开展的一项针对感染性休克患者的多中心观察性研究:类固醇疗法
Intern Med. 2024 Dec 15;63(24):3307-3315. doi: 10.2169/internalmedicine.1511-22. Epub 2024 May 9.
4
Association between reduced muscle mass and poor prognosis of biliary sepsis.肌肉减少症与胆道感染预后不良的关系。
Sci Rep. 2024 Jan 22;14(1):1857. doi: 10.1038/s41598-024-52502-9.
5
Decoding Sepsis-Induced Disseminated Intravascular Coagulation: A Comprehensive Review of Existing and Emerging Therapies.解读脓毒症诱导的弥散性血管内凝血:现有及新兴疗法的全面综述
J Clin Med. 2023 Sep 22;12(19):6128. doi: 10.3390/jcm12196128.
6
Pathophysiology of Disseminated Intravascular Coagulation in Sepsis: A Clinically Focused Overview.脓毒症弥散性血管内凝血的病理生理学:临床重点概述。
Cells. 2023 Aug 22;12(17):2120. doi: 10.3390/cells12172120.
7
Modifications of peripheral perfusion in patients with vasopressor-dependent septic shock treated with polymyxin B-direct hemoperfusion.多黏菌素 B 直接血液灌流治疗血管加压素依赖性脓毒性休克患者外周灌注的改变。
Sci Rep. 2023 May 5;13(1):7295. doi: 10.1038/s41598-023-34084-0.
8
Early Mobilization for Critically Ill Patients.危重症患者的早期活动
Respir Care. 2023 Jun;68(6):781-795. doi: 10.4187/respcare.10481. Epub 2023 Apr 11.
9
Thrombocytopenia, anasarca, and renal insufficiency as severe and rare complications of Hodgkin lymphoma: a case report.血小板减少症、全身水肿和肾功能不全作为霍奇金淋巴瘤的严重且罕见并发症:一例报告。
J Med Case Rep. 2023 Feb 21;17(1):61. doi: 10.1186/s13256-023-03776-6.
10
Effect of Anticoagulant Versus Non-Anticoagulant Therapy on Mortality of Sepsis-Induced Disseminated Intravascular Coagulation: A Systematic Review and Meta-Analysis.抗凝与非抗凝治疗对脓毒症诱导弥散性血管内凝血患者死亡率的影响:系统评价和荟萃分析。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231157766. doi: 10.1177/10760296231157766.

本文引用的文献

1
Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis.左西孟旦用于预防脓毒症急性器官功能障碍
N Engl J Med. 2016 Oct 27;375(17):1638-1648. doi: 10.1056/NEJMoa1609409. Epub 2016 Oct 5.
2
Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.氢化可的松对严重脓毒症患者休克发生的影响:HYPRESS随机临床试验
JAMA. 2016 Nov 1;316(17):1775-1785. doi: 10.1001/jama.2016.14799.
3
Esophageal and transpulmonary pressure in the clinical setting: meaning, usefulness and perspectives.临床环境中的食管压和跨肺压:意义、用途和展望。
Intensive Care Med. 2016 Sep;42(9):1360-73. doi: 10.1007/s00134-016-4400-x. Epub 2016 Jun 22.
4
Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial.早期与延迟启动肾脏替代治疗对急性肾损伤危重症患者死亡率的影响:ELAIN 随机临床试验。
JAMA. 2016;315(20):2190-9. doi: 10.1001/jama.2016.5828.
5
Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit.重症监护病房肾脏替代治疗的启动策略。
N Engl J Med. 2016 Jul 14;375(2):122-33. doi: 10.1056/NEJMoa1603017. Epub 2016 May 15.
6
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.降钙素原指导在危重症患者中缩短抗生素治疗时间的疗效和安全性:一项随机、对照、开放标签试验。
Lancet Infect Dis. 2016 Jul;16(7):819-827. doi: 10.1016/S1473-3099(16)00053-0. Epub 2016 Mar 2.
7
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).《脓毒症及脓毒性休克第三次国际共识定义(脓毒症-3)》
JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.
8
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).制定脓毒性休克的新定义并评估新的临床标准:用于第三次脓毒症和脓毒性休克国际共识定义(Sepsis-3)。
JAMA. 2016 Feb 23;315(8):775-87. doi: 10.1001/jama.2016.0289.
9
Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).脓毒症临床标准评估:针对《脓毒症及脓毒性休克第三次国际共识定义》(Sepsis-3)。
JAMA. 2016 Feb 23;315(8):762-74. doi: 10.1001/jama.2016.0288.
10
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.严重脓毒症的β-内酰胺输注(BLISS):一项前瞻性、双中心、开放标签随机对照试验,比较了连续性与间歇性β-内酰胺输注在重症严重脓毒症患者中的应用。
Intensive Care Med. 2016 Oct;42(10):1535-1545. doi: 10.1007/s00134-015-4188-0. Epub 2016 Jan 11.

《2016年日本脓毒症及脓毒性休克管理临床实践指南》(J-SSCG 2016)

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).

作者信息

Nishida Osamu, Ogura Hiroshi, Egi Moritoki, Fujishima Seitaro, Hayashi Yoshiro, Iba Toshiaki, Imaizumi Hitoshi, Inoue Shigeaki, Kakihana Yasuyuki, Kotani Joji, Kushimoto Shigeki, Masuda Yoshiki, Matsuda Naoyuki, Matsushima Asako, Nakada Taka-Aki, Nakagawa Satoshi, Nunomiya Shin, Sadahiro Tomohito, Shime Nobuaki, Yatabe Tomoaki, Hara Yoshitaka, Hayashida Kei, Kondo Yutaka, Sumi Yuka, Yasuda Hideto, Aoyama Kazuyoshi, Azuhata Takeo, Doi Kent, Doi Matsuyuki, Fujimura Naoyuki, Fuke Ryota, Fukuda Tatsuma, Goto Koji, Hasegawa Ryuichi, Hashimoto Satoru, Hatakeyama Junji, Hayakawa Mineji, Hifumi Toru, Higashibeppu Naoki, Hirai Katsuki, Hirose Tomoya, Ide Kentaro, Kaizuka Yasuo, Kan'o Tomomichi, Kawasaki Tatsuya, Kuroda Hiromitsu, Matsuda Akihisa, Matsumoto Shotaro, Nagae Masaharu, Onodera Mutsuo, Ohnuma Tetsu, Oshima Kiyohiro, Saito Nobuyuki, Sakamoto So, Sakuraya Masaaki, Sasano Mikio, Sato Norio, Sawamura Atsushi, Shimizu Kentaro, Shirai Kunihiro, Takei Tetsuhiro, Takeuchi Muneyuki, Takimoto Kohei, Taniguchi Takumi, Tatsumi Hiroomi, Tsuruta Ryosuke, Yama Naoya, Yamakawa Kazuma, Yamashita Chizuru, Yamashita Kazuto, Yoshida Takeshi, Tanaka Hiroshi, Oda Shigeto

机构信息

1Department of Anesthesiology and Critical Care Medicine, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192 Japan.

2Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

出版信息

J Intensive Care. 2018 Feb 2;6:7. doi: 10.1186/s40560-017-0270-8. eCollection 2018.

DOI:10.1186/s40560-017-0270-8
PMID:29435330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5797365/
Abstract

BACKGROUND AND PURPOSE

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016), a Japanese-specific set of clinical practice guidelines for sepsis and septic shock created jointly by the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine, was first released in February 2017 and published in , [2017; Volume 24 (supplement 2)] 10.3918/jsicm.24S0001 and [2017; Volume 28, (supplement 1)] http://onlinelibrary.wiley.com/doi/10.1002/jja2.2017.28.issue-S1/issuetoc.This abridged English edition of the J-SSCG 2016 was produced with permission from the Japanese Association of Acute Medicine and the Japanese Society for Intensive Care Medicine.

METHODS

Members of the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine were selected and organized into 19 committee members and 52 working group members. The guidelines were prepared in accordance with the Medical Information Network Distribution Service (Minds) creation procedures. The Academic Guidelines Promotion Team was organized to oversee and provide academic support to the respective activities allocated to each Guideline Creation Team. To improve quality assurance and workflow transparency, a mutual peer review system was established, and discussions within each team were open to the public. Public comments were collected once after the initial formulation of a clinical question (CQ) and twice during the review of the final draft. Recommendations were determined to have been adopted after obtaining support from a two-thirds (> 66.6%) majority vote of each of the 19 committee members.

RESULTS

A total of 87 CQs were selected among 19 clinical areas, including pediatric topics and several other important areas not covered in the first edition of the Japanese guidelines (J-SSCG 2012). The approval rate obtained through committee voting, in addition to ratings of the strengths of the recommendation, and its supporting evidence were also added to each recommendation statement. We conducted meta-analyses for 29 CQs. Thirty-seven CQs contained recommendations in the form of an expert consensus due to insufficient evidence. No recommendations were provided for five CQs.

CONCLUSIONS

Based on the evidence gathered, we were able to formulate Japanese-specific clinical practice guidelines that are tailored to the Japanese context in a highly transparent manner. These guidelines can easily be used not only by specialists, but also by non-specialists, general clinicians, nurses, pharmacists, clinical engineers, and other healthcare professionals.

摘要

背景与目的

《2016年日本脓毒症及脓毒性休克管理临床实践指南》(J-SSCG 2016)是由日本重症医学会和日本急性医学协会联合制定的一套针对日本国情的脓毒症及脓毒性休克临床实践指南,于2017年2月首次发布,并发表于[2017年;第24卷(增刊2)] 10.3918/jsicm.24S0001以及[2017年;第28卷,(增刊1)] http://onlinelibrary.wiley.com/doi/10.1002/jja2.2017.28.issue-S1/issuetoc。本J-SSCG 2016的英文节略版经日本急性医学协会和日本重症医学会许可制作。

方法

挑选日本重症医学会和日本急性医学协会的成员,组成19名委员会成员和52名工作组成员。指南按照医学信息网络分发服务(Minds)的制定程序编写。组建学术指南推广团队,以监督并为分配给每个指南制定团队的各自活动提供学术支持。为提高质量保证和工作流程透明度,建立了相互同行评审系统,每个团队内部的讨论向公众开放。在最初提出临床问题(CQ)后收集一次公众意见,在最终草案评审期间收集两次。在获得19名委员会成员中三分之二(>66.6%)多数票的支持后,确定建议被采纳。

结果

在19个临床领域共挑选出87个CQ,包括儿科主题以及日本指南第一版(J-SSCG 2012)未涵盖的其他几个重要领域。通过委员会投票获得的批准率,以及建议强度评级和支持证据也被添加到每个建议声明中。我们对29个CQ进行了荟萃分析。由于证据不足,37个CQ包含专家共识形式的建议。5个CQ未提供建议。

结论

基于收集到的证据,我们能够以高度透明的方式制定适合日本国情的日本特定临床实践指南。这些指南不仅专科医生可以轻松使用,非专科医生、普通临床医生、护士、药剂师、临床工程师和其他医疗保健专业人员也可以轻松使用。